Similar articles

• High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.

  Martelli M, Vignetti M, Zinzani PL, Gherlinzoni F, Meloni G, Fiacchini M, De Sanctis V, Papa G, Martelli MF, Calabresi F, Tura S, Mandelli F. Martelli M, et al. J Clin Oncol. 1996 Feb;14(2):534-42. doi: 10.1200/JCO.1996.14.2.534. J Clin Oncol. 1996. PMID: 8636768 Clinical Trial.
• CA and leukemia group B 9251 protocol.

  Zitter K, DeVos D. Zitter K, et al. Radiol Technol. 1997 May-Jun;68(5):423-5. Radiol Technol. 1997. PMID: 9170185 No abstract available.
• [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].

  Bron D, Vandenheule B, Stryckmans P. Bron D, et al. Rev Med Brux. 1985 Sep;6(7):491-5. Rev Med Brux. 1985. PMID: 2417298 Review. French. No abstract available.
• [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].

  Imura H, Ito N, Shirakawa S, Sobue R, Maruyama F, Kojima H, Shinkai K, Matsui T, Ino T, Shimizu K, et al. Imura H, et al. Rinsho Ketsueki. 1988 May;29(5):688-93. Rinsho Ketsueki. 1988. PMID: 3216495 Japanese. No abstract available.
• Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?

  Gaynor ER, Fisher RI. Gaynor ER, et al. Oncology (Williston Park). 1995 Dec;9(12):1273-9; discussion 1283-4. Oncology (Williston Park). 1995. PMID: 8771102 Review.